Update, October 2026: TB-500 is now available. Log in to your Rebody account to speak with a clinician and get started. Some information below may be out of date.
The short answer
The best TB-500 option is the one whose label verifies the exact seven-amino-acid form, concentration, usable supply, and cost per prescribed day.
Options at a glance
| Option | What changes | What must be verified | Boundary |
|---|---|---|---|
| 5 mg TB-500 vial | Total active and refill burden | Exact identity, concentration, supply | Best when it covers the course without waste |
| 10 mg TB-500 vial | Total active and up-front price | Beyond-use date and cost per day | Best when the full quantity is usable |
What belongs in this category
A TB-500 page must start with identity. The vial should name the exact seven-amino-acid substance rather than using “thymosin” as shorthand. Once identity is verified, compare concentration, total supply, storage, and refill timing.
Five and ten milligrams describe total quantity. They do not prove that a larger vial works better.
What these molecules are
TB-500 commonly refers to an acetylated seven-amino-acid sequence related to residues 17–23 of thymosin beta-4. Full thymosin beta-4 is a 43-amino-acid protein. The non-acetylated LKKTETQ fragment used in some laboratory work is also not automatically identical to an acetylated finished vial.
That is why a TB-500 label needs more than a brand-like name. Exact sequence or substance, concentration, fill volume, total active, and the prescription must agree.
What the research measured
FDA's review identified no human TB-500 exposure, pharmacokinetic, safety, or efficacy study by any route. In the direct laboratory record, a fibroblast scratch assay using 50 micrograms per milliliter for eight hours found no significant wound-closure difference from vehicle.
Frequently cited wound work tested full thymosin beta-4 or a non-acetylated fragment in laboratory or animal models. Those results belong to the exact molecule tested. Package size changes convenience, not molecular identity.
Which option wins this comparison
Choose a TB-500 vial only after exact identity is verified. Among verified options, the practical winner covers the prescribed course at the lower cost per day without exceeding the beyond-use date or creating avoidable refill gaps.
The 10 mg vial wins on supply only when the extra quantity is usable. The 5 mg vial wins when it better matches a shorter course or avoids waste.
Strength and concentration are different facts
Keep total active and concentration separate. Your clinician sets the dose, timing, and use. Follow your prescription label. Ask the dispensing pharmacy to explain the label if it is unclear.
Do not borrow directions from thymosin beta-4 studies, a competitor's vial, or a forum stack. Do not combine TB-500 with another active unless your clinician directs it.
What changes in real life
Plan for sharps disposal, storage, travel, and refill lead time across the full course. If work or travel gets in the way, ask the care team for help.
Storage, shipping, and travel
Use the finished TB-500 vial's exact storage and after-opening instructions. Do not borrow a temperature range from BPC-157, KPV, or full thymosin beta-4. Keep the lot and beyond-use date with the original label.
After excess heat, freezing, a broken seal, crack, leak, cloudiness, particles, or color change, hold the product and contact the dispensing pharmacy. During travel, plan for sharps handling.
Side effects and urgent symptoms
No identified human TB-500 study establishes systemic safety. Immediate injection risks include pain, bruising, bleeding, irritation, contamination, and infection. Spreading warmth or redness, drainage, red streaking, fever, facial swelling, breathing difficulty, or fainting needs prompt help.
Tested athletes must also account for anti-doping rules. Pregnancy, breastfeeding, cancer or immune treatment, clotting concerns, and medication interactions require direct clinician review.
Price, supply, and refills
Calculate price per prescribed day from verified supply, not the vial's milligram headline. Include syringes, swabs, shipping, storage equipment if needed, and the number of refills required for the course.
A larger vial is better value only when the beyond-use date allows the full amount to be used. Otherwise the lower per-milligram price can hide waste.
Questions people ask before starting
What are the risks of taking TB-500?
FDA's review identified no human TB-500 exposure, pharmacokinetic, safety, or efficacy study. Injection risks include pain, bruising, contamination, and infection, and TB-500 is prohibited for tested athletes. Package size does not change that safety record.
Is TB-500 the same as thymosin beta-4?
No. TB-500 commonly refers to a seven-amino-acid fragment related to residues 17–23 of thymosin beta-4. Thymosin beta-4 is a 43-amino-acid protein, so its human wound studies cannot be presented as TB-500 trials. Exact identity must be verified before comparing concentration, supply, or price.
What changes between 5 mg and 10 mg vials?
Five and ten milligrams usually describe total active in the vial. Concentration, days of supply, price, and refill timing decide which package is more practical. The winner covers the prescribed course without waste.
What did the strongest study measure?
The most relevant fragment evidence comes from aged-mouse wounds and laboratory migration or sprouting assays; full thymosin beta-4 and TB-500 must remain separate.
How do route and product form change the answer?
The direct TB-500 record is preclinical; human studies of full thymosin beta-4 belong to the 43-amino-acid parent protein.
How should the product be stored for travel?
For a TB-500 vial, travel with the product in its original labeled container and follow the label's temperature range. After a warm shipment, leak, crack, broken seal, cloudiness, particles, or color change, hold the product for guidance from the dispensing pharmacy; the finished formula controls the answer.
Is a 10 mg TB-500 vial a higher dose than a 5 mg vial?
Not by itself. Ten milligrams states the total quantity in the vial. A larger vial may also use a different fill volume. Your clinician sets the dose. Follow your prescription label.
How can a label prove the vial is actually TB-500?
The label and product documentation should identify the exact substance, not merely say “thymosin.” TB-500 commonly refers to an acetylated seven-amino-acid fragment related to thymosin beta-4, while the parent protein contains 43 amino acids. Concentration, fill volume, and total active should all agree.
What should happen to TB-500 during travel?
Carry it in the original labeled container, follow the label's temperature range, and keep used sharps in a proper container. Check airline and destination requirements. After excess heat, accidental freezing, a leak, crack, broken seal, cloudiness, particles, or color change, hold the product for pharmacy guidance.
Verify identity first
"Thymosin" on its own is too vague. Full thymosin beta-4 has 43 amino acids; TB-500 commonly refers to a shorter acetylated fragment related to the LKKTETQ region; some laboratory papers test an unacetylated fragment. A finished vial should identify the actual substance. Once identity is clear, concentration, volume, total active, storage, and supply become meaningful. Human topical thymosin beta-4 findings remain attached to the parent protein, while TB-500 retains its narrower fragment record.
Free base, acetate, and acetylated are three different words
Shoppers often treat these terms as one idea. They describe different things. "Acetylated" describes a change to the peptide chain itself: an acetyl group joined to the sequence. TB-500 is commonly described as acetylated. "Acetate" usually names a salt form, where the peptide carries acetate counterions from manufacturing that are not part of the sequence. "Free base" names the peptide without that salt. One vial can hold an acetylated fragment supplied as an acetate salt, so each word answers a separate question.
Why salt form matters on the label
Salt form changes what a milligram figure means. A label may state the weight of the salt, or it may state the weight of the peptide alone. For one vial, those two numbers differ. Ask the dispensing pharmacy which basis the label uses. Compare two products only when both labels use the same basis. Without that check, a lower price per milligram can hide less active peptide.
What the research does not answer yet
The cited sources do not compare a free-base TB-500 product with an acetate-salt product. They report no human exposure for either form, and the FDA review found no human TB-500 study of any kind. The aged-mouse wound work tested full thymosin beta-4 and a non-acetylated fragment, so it says nothing about salt form in a finished vial. Any stability difference between forms in a finished product stays a label and pharmacy question here, not a research finding.
Common questions about chemical form
Is TB-500 acetate a different drug from TB-500 free base?
The sequence can be identical. The salt changes the weight on the label and can change how the powder handles during compounding. The label should say which form the vial holds.
Does the acetate form make TB-500 work better?
No source cited here tests that claim. Treat marketing that ranks one form above the other as unproven.
Why do some sellers list only "TB-500" with no form at all?
A bare name leaves out the salt and the acetylation state. Ask for the full substance name before comparing price or supply.
Bottom line
The best TB-500 option is the one whose label verifies the exact seven-amino-acid form, concentration, usable supply, and cost per prescribed day.
Keep reading
- At-Home Peptide Injections for Recovery
- TB-500 Injection Supplies, Storage, and Travel
- Recovery Peptide Injections
Primary sources
- https://pubmed.ncbi.nlm.nih.gov/12581423/
- https://pubmed.ncbi.nlm.nih.gov/14500546/
- https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
- https://www.wada-ama.org/en/resources/world-anti-doping-code-and-international-standards/prohibited-list